NOVARTIS AG-SPONSORED ADR (NVS) Stock Price, Quote, News and Overview
NYSE:NVS - New York Stock Exchange, Inc. - US66987V1098 - ADR - Currency: USD
NVS Quote, Performance and Key Statistics
NYSE:NVS (5/2/2025, 2:25:59 PM)
114.18
+2.85 (+2.56%)
The current stock price of NVS is 114.18 USD. In the past month the price increased by 0.51%. In the past year, price increased by 14.45%.
NVS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 59.86 | 780.80B | ||
| JNJ | JOHNSON & JOHNSON | 15.51 | 375.72B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 20 | 307.16B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 19.46 | 224.45B | ||
| MRK | MERCK & CO. INC. | 10.7 | 209.79B | ||
| PFE | PFIZER INC | 7.54 | 137.25B | ||
| SNY | SANOFI-ADR | 14.37 | 135.75B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.84 | 102.23B | ||
| GSK | GSK PLC-SPON ADR | 7.04 | 78.46B | ||
| ZTS | ZOETIS INC | 26.53 | 70.04B | ||
| HLN | HALEON PLC-ADR | 21.81 | 48.21B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 33.27 | 48.17B |
Related stock screener links
About NVS
Company Profile
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. The company is headquartered in Basel, Basel-Stadt and currently employs 75,883 full-time employees. The company went IPO on 2001-05-07. The firm develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The firm uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
Company Info
NOVARTIS AG-SPONSORED ADR
Lichtstrasse 35
Basel BASEL-STADT CH 4056 CH
CEO: Vasant (Vas) Narasimhan
Employees: 76057
Company Website: https://www.novartis.com/
Investor Relations: https://www.novartis.com/investors
Phone: 41613241111
NOVARTIS AG-SPONSORED ADR / NVS FAQ
What is the stock price of NOVARTIS AG-SPONSORED ADR today?
The current stock price of NVS is 114.18 USD. The price increased by 2.56% in the last trading session.
What is the ticker symbol for NOVARTIS AG-SPONSORED ADR stock?
The exchange symbol of NOVARTIS AG-SPONSORED ADR is NVS and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is NVS stock listed?
NVS stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for NOVARTIS AG-SPONSORED ADR stock?
32 analysts have analysed NVS and the average price target is 128.81 USD. This implies a price increase of 12.82% is expected in the next year compared to the current price of 114.18. Check the NOVARTIS AG-SPONSORED ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NOVARTIS AG-SPONSORED ADR worth?
NOVARTIS AG-SPONSORED ADR (NVS) has a market capitalization of 225.52B USD. This makes NVS a Mega Cap stock.
How many employees does NOVARTIS AG-SPONSORED ADR have?
NOVARTIS AG-SPONSORED ADR (NVS) currently has 76057 employees.
What are the support and resistance levels for NOVARTIS AG-SPONSORED ADR (NVS) stock?
NOVARTIS AG-SPONSORED ADR (NVS) has a support level at 110.2 and a resistance level at 111.72. Check the full technical report for a detailed analysis of NVS support and resistance levels.
Is NOVARTIS AG-SPONSORED ADR (NVS) expected to grow?
The Revenue of NOVARTIS AG-SPONSORED ADR (NVS) is expected to grow by 6.4% in the next year. Check the estimates tab for more information on the NVS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NOVARTIS AG-SPONSORED ADR (NVS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NVS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NVS, evaluating the profitability, health, valuation and growth aspects
- NOVARTIS AG-SPONSORED ADR (NVS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NOVARTIS AG-SPONSORED ADR (NVS) Sales and EPS estimates to see what analysts future expectations are.
- NOVARTIS AG-SPONSORED ADR (NVS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NOVARTIS AG-SPONSORED ADR (NVS) Insider and Institutional Ownership to learn about the owners and their transactions.
- NOVARTIS AG-SPONSORED ADR (NVS) Stock Chart to make your own analysis
- NOVARTIS AG-SPONSORED ADR (NVS) Latest news and press-releases to stay up to date.
Does NOVARTIS AG-SPONSORED ADR (NVS) stock pay dividends?
NOVARTIS AG-SPONSORED ADR (NVS) has a dividend yield of 3.73%. The yearly dividend amount is currently 3.79. Check the full fundamental report for a detailed analysis of NVS dividend history, reliability and sustainability.
When does NOVARTIS AG-SPONSORED ADR (NVS) report earnings?
NOVARTIS AG-SPONSORED ADR (NVS) will report earnings on 2025-07-17, before the market open.
What is the Price/Earnings (PE) ratio of NOVARTIS AG-SPONSORED ADR (NVS)?
The PE ratio for NOVARTIS AG-SPONSORED ADR (NVS) is 13.74. This is based on the reported non-GAAP earnings per share of 8.31 and the current share price of 114.18 USD. Check the full fundamental report for a full analysis of the valuation metrics for NVS.
What is the Short Interest ratio of NOVARTIS AG-SPONSORED ADR (NVS) stock?
The outstanding short interest for NOVARTIS AG-SPONSORED ADR (NVS) is 0.27% of its float. Check the ownership tab for more information on the NVS short interest.
NVS Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to NVS. When comparing the yearly performance of all stocks, NVS is one of the better performing stocks in the market, outperforming 85.58% of all stocks.
NVS Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to NVS. Both the health and profitability get an excellent rating, making NVS a very profitable company, without any liquidiy or solvency issues.
NVS Financial Highlights
Over the last trailing twelve months NVS reported a non-GAAP Earnings per Share(EPS) of 8.31. The EPS increased by 18.6% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 24.15% | ||
| ROA | 12.87% | ||
| ROE | 33.51% | ||
| Debt/Equity | 0.61 |
NVS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 68% to NVS. The Buy consensus is the average rating of analysts ratings from 32 analysts.
For the next year, analysts expect an EPS growth of 11.31% and a revenue growth 6.4% for NVS